The NHS in Essex is piloting a quick, safe and simple test that could help identify patients at risk of oesophageal cancer much earlier. The new Capsule Sponge test is being offered at a GP practice in Chelmsford to selected patients with long-term acid reflux. The procedure takes around seven minutes, requires no sedation, and can be carried out entirely within the GP surgery. It allows doctors to identify people who may need further investigation sooner, while reassuring those who do not.
Procedure Details and Purpose
Dr Andrea Oustayiannis, a Macmillan GP leading the clinic pilot, said: “Having heartburn increases the risk of cell changes in the food pipe. Most people won't go on to develop cancer, but spotting these changes early gives us the best chance of preventing more serious illness.” The test is designed to detect Barrett’s oesophagus, a condition linked to a higher risk of cancer, as well as early precancerous changes. Evidence shows the test is highly accurate and can identify far more cases in general practice than usual care.
Patient Experience and Safety
Dr Oustayiannis added: “The test itself is safe and straightforward. You swallow a small capsule about the size of a vitamin pill on a thread; once it reaches your stomach, it dissolves and releases a tiny sponge. We gently pull the sponge back up, and it collects cells from your oesophagus that are then checked in a lab. There’s no need for sedation, and you can get straight back to your day afterwards.” Alongside the test, patients will receive advice on reducing their risk of cancer, including support around smoking and weight management.
Impact on NHS Services
Dr Elizabeth Towers, a Macmillan GP involved in the project, said: “Introducing the Capsule Sponge test into general practice gives us a simple and less invasive way to identify patients at risk of oesophageal conditions much earlier. For patients, it means quicker answers and fewer hospital appointments. For the wider NHS, it helps us reduce pressure on endoscopy services and focus specialist care where it’s needed most. Through this pilot, we hope to demonstrate how innovative diagnostics in primary care could improve outcomes while easing demand across the NHS.”
Pilot Scope and Evaluation
The pilot supports local NHS priorities to help people stay healthier for longer and access more care closer to home. It aims to see around 250 patients within two years and will be fully evaluated to understand its impact.
